2008 | Searcy Law Skip to Content
Contact Form Live Chat Review Us Map & Directions Videos

Yearly Archives: 2008

Levaquin and Serious Tendon Ruptures

11/26/2008
Blog
BY

Levaquin (also known as levofloxacin) is a popular antibiotic that has been used for years for the treatment of upper respiratory infections, urinary tract infections, prostatitis, and bacterial infections.  It is part of a class of drugs known as fluoroquinolones, which were first marketed in the United States in 1997.  […]

Read More

When Will The Bad News About Vioxx End?

11/24/2008
Blog
BY

Merck’s nightmare over Vioxx continues.  This is one that has cost the company dearly – on Wall Street, among physicians, in scientific circles, in the judicial system, and in the court of public opinion.  The latest blow came from the New England Journal of Medicine which published additional information regarding […]

Read More

Seeking to Hold Big Tobacco Accountable

11/20/2008
Blog
BY

A novel lawsuit is winding its way through the courts in St. Louis.  Thirty Missouri hospitals are pursuing claims against Altria (the parent company of Phillip Morris) and other tobacco manufacturers for the costs of medical care provided to patients with tobacco-induced diseases who were uninsured or unable to pay […]

Read More

In Search of Safer Alternative to Gadolinium-Based Contrast Agents

11/19/2008
Blog
BY

A recent study published in Kidney International, the journal of the International Society of Nephrology, noted increasing concerns over the use of gadolinium-based contrast agents in patients with renal or liver disease.  In this article, researchers from the Oregon Health and Science University urged the use of ultrasmall superparamagnetic iron […]

Read More

Cornell Study Defines Broad Spectrum of Patients at Risk for Development of Gadolinium-Induced Complications

10/31/2008
Blog
BY

A September of 2008 study published in the journal Radiology, sought to further identify those patients most at risk for the development of nephrogenic systemic fibrosis (NSF) as a result of exposure to gadolinium-based contrast agents.  Nephrogenic systemic fibrosis is an incurable, devastating disease that manifests itself as significant skin […]

Read More